Search Results - "Showell, G A"
-
1
Silicon switches of marketed drugs
Published in Mini reviews in medicinal chemistry (01-10-2006)“…The application of organosilicon chemistry is a strategy to develop best in class drugs applied to targets that have been validated as tractable and drug-able…”
Get more information
Journal Article -
2
Chemistry challenges in lead optimization: silicon isosteres in drug discovery
Published in Drug Discovery Today (15-06-2003)“…During the lead optimization phase of drug discovery projects, the factors contributing to subsequent failure might include poor portfolio decision-making and…”
Get full text
Book Review Journal Article -
3
Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors
Published in Journal of medicinal chemistry (01-10-1990)“…The synthesis and biochemical evaluation of novel 1,2,4-oxadiazole-based muscarinic agonists which can readily penetrate into the CNS is reported. Efficacy and…”
Get full text
Journal Article -
4
Tetrahydropyridyloxadiazoles : semirigid muscarinic ligands
Published in Journal of medicinal chemistry (01-03-1991)“…Recent studies have described novel azabicycle-based muscarinic agonists which readily penetrate into the central nervous system and are capable of displaying…”
Get full text
Journal Article -
5
4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines : Selective h5-HT1D agonists for the treatment of migraine
Published in Bioorganic & medicinal chemistry letters (06-12-1999)“…A series of 4-hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl] piperidines was investigated as potential selective h5-HT1D agonists for the treatment…”
Get full text
Journal Article -
6
Sila-venlafaxine, a Sila-Analogue of the Serotonin/Noradrenaline Reuptake Inhibitor Venlafaxine: Synthesis, Crystal Structure Analysis, and Pharmacological Characterization
Published in Organometallics (27-02-2006)“…The serotonin/noradrenaline reuptake inhibitor rac-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol (rac-venlafaxine, rac-1a) is in clinical use…”
Get full text
Journal Article -
7
L-687,306: a functionally selective and potent muscarinic M1 receptor agonist
Published in European journal of pharmacology (29-04-1992)“…The oxadiazole L-687,306 is a high affinity muscarinic agonist with a N-methylscopolamine/oxotremorine-M binding profile predictive of a partial agonist…”
Get more information
Journal Article -
8
Selective thyromimetics. Cardiac-sparing thyroid hormone analogs containing 3'-arylmethyl substituents
Published in Journal of medicinal chemistry (01-02-1989)“…Introduction of specific arylmethyl groups at the 3'-position of the thyroid hormone 3,3',5-triiodo-L-thyronine (T3), and its known hormonally active…”
Get full text
Journal Article -
9
Synthesis and antihypertensive activity of 6,7-disubstituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols
Published in Journal of medicinal chemistry (01-09-1984)“…A series of novel 6,7-disubstituted trans-3,4-dihydro-2, 2-dimethyl-4-pyrrolidino-(or piperidino)-2H-1-benzopyran-3-ols was prepared and tested for…”
Get full text
Journal Article -
10
2-Methyl-1,3-dioxaazaspiro[4.5]decanes as novel muscarinic cholinergic agonists
Published in Journal of medicinal chemistry (01-02-1988)“…Many nonquaternary ammonium muscarinic agonists have been developed over the last few years, but most of the existing compounds (e.g., arecoline, RS-86, AF-30)…”
Get full text
Journal Article -
11
-
12
Approaches to rational drug development in Alzheimer's disease
Published in Drug design and discovery (1993)Get more information
Journal Article -
13
Design strategies for building drug-like chemical libraries
Published in Current opinion in drug discovery & development (01-05-2001)“…There has been increased pressure over the last few years to design and synthesize chemical libraries that are more 'drug-like' in character. This review…”
Get more information
Journal Article -
14
Exploitation of silicon medicinal chemistry in drug discovery
Published in Expert opinion on investigational drugs (01-09-2004)“…There remains considerable pressure on the pharmaceutical industry to increase productivity and reduce the attrition of drug candidates. Genomics, parallel…”
Get more information
Journal Article -
15
Thyroid hormone analogs. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart
Published in Journal of medicinal chemistry (01-01-1988)“…Twenty-nine novel 3'-substituted derivatives of the thyroid hormone 3,3',5-triiodo-L-thyronine (T3) have been synthesized by using established methods and by a…”
Get full text
Journal Article -
16
Synthesis, Crystal Structure Analysis, and Pharmacological Characterization of Disila-bexarotene, a Disila-Analogue of the RXR-Selective Retinoid Agonist Bexarotene
Published in Organometallics (20-06-2005)“…Twofold sila-substitution (C/Si exchange) in the saturated ring of the tetrahydronaphthalene skeleton of the RXR-selective retinoid agonist bexarotene (1a)…”
Get full text
Journal Article -
17
( R)-Sila-venlafaxine: A selective noradrenaline reuptake inhibitor for the treatment of emesis
Published in Bioorganic & medicinal chemistry letters (01-05-2006)“…The in vitro profile and in vivo anti-emetic activity of the selective noradrenaline reuptake inhibitor ( R )- 2 are reported. Sila-substitution of drugs (the…”
Get full text
Journal Article -
18
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor
Published in Bioorganic & medicinal chemistry (01-10-1998)“…Two novel series of 3-(heterocyclylmethyl)pyrazoles have been synthesised and evaluated as ligands for the human dopamine D4 receptor. Compounds in series I…”
Get full text
Journal Article -
19
Binding of 2,4-disubstituted morpholines at human D4 dopamine receptors
Published in Bioorganic & medicinal chemistry (01-01-1998)“…The synthesis of a series of 2,4-disubstituted morpholines is described and their affinities at human dopamine receptors reported. The orally bioavailable…”
Get full text
Journal Article -
20
The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3)
Published in Journal of peptide science (01-03-2005)“…Extensive SAR studies on the unselective BRS3 agonist, [H‐D‐Phe6,β‐Ala11,Phe13,Nle14]‐bombesin‐(6‐14)‐nonapeptide amide, have highlighted structural features…”
Get full text
Journal Article